Literature DB >> 17331505

Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis.

Saravanababu Murugesan1, Shaker A Mousa, Laura J O'connor, David W Lincoln, Robert J Linhardt.   

Abstract

Angiogenesis is important for normal growth and wound healing processes. An imbalance of the growth factors involved in this process, however, causes the acceleration of several diseases including malignant, ocular, and inflammatory diseases. Inhibiting angiogenesis through interfering with its pathway is a promising methodology to hinder the progression of these diseases. Herein, we studied the anti-angiogenic effects of various carbon materials such as graphite, multiwalled carbon nanotubes and fullerenes in vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF2)-induced angiogenesis evaluated in the chick chorioallantoic membrane (CAM) model. All the carbon materials tested showed substantial anti-angiogenic activity against either FGF2- or VEGF-induced angiogenesis in the CAM model. Those carbon materials did not have any significant effects on basal angiogenesis in the absence of the added growth factors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331505      PMCID: PMC1994254          DOI: 10.1016/j.febslet.2007.02.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 2.  Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.

Authors:  D Ribatti; B Nico; A Vacca; L Roncali; P H Burri; V Djonov
Journal:  Anat Rec       Date:  2001-12-01

Review 3.  Angiogenesis in life, disease and medicine.

Authors:  Peter Carmeliet
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

4.  Blood compatible carbon nanotubes--nano-based neoproteoglycans.

Authors:  Saravanababu Murugesan; Tae-Joon Park; Hoichang Yang; Shaker Mousa; Robert J Linhardt
Journal:  Langmuir       Date:  2006-04-11       Impact factor: 3.882

5.  Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated.

Authors:  Shaker A Mousa; Laura O'Connor; Faith B Davis; Paul J Davis
Journal:  Endocrinology       Date:  2005-12-29       Impact factor: 4.736

Review 6.  Nano-oncology: drug delivery, imaging, and sensing.

Authors:  Nathaniel G Portney; Mihrimah Ozkan
Journal:  Anal Bioanal Chem       Date:  2006-01-27       Impact factor: 4.142

7.  Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.

Authors:  Faith B Davis; Shaker A Mousa; Laura O'Connor; Seema Mohamed; Hung-Yun Lin; H James Cao; Paul J Davis
Journal:  Circ Res       Date:  2004-04-29       Impact factor: 17.367

8.  Applications of Carbon Nanotubes in Biotechnology and Biomedicine.

Authors:  Elena Bekyarova; Yingchun Ni; Erik B Malarkey; Vedrana Montana; Jared L McWilliams; Robert C Haddon; Vladimir Parpura
Journal:  J Biomed Nanotechnol       Date:  2005-03-01       Impact factor: 4.099

9.  Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.

Authors:  Ravi Singh; Davide Pantarotto; Lara Lacerda; Giorgia Pastorin; Cédric Klumpp; Maurizio Prato; Alberto Bianco; Kostas Kostarelos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

Review 10.  A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors.

Authors:  Ron Hardman
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

View more
  20 in total

1.  Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice.

Authors:  Shoukang Zhu; Anuj Malhotra; Lisheng Zhang; Shanming Deng; Taifang Zhang; Neil J Freedman; Robert Storms; Karsten Peppel; Pascal J Goldschmidt-Clermont; Chunming Dong
Journal:  Atherosclerosis       Date:  2010-04-21       Impact factor: 5.162

2.  Using water-soluble C60 fullerenes in anticancer therapy.

Authors:  S V Prylutska; A P Burlaka; P P Klymenko; I I Grynyuk; Yu I Prylutskyy; Ch Schütze; U Ritter
Journal:  Cancer Nanotechnol       Date:  2011-08-19

3.  Distribution of single wall carbon nanotubes in the Xenopus laevis embryo after microinjection.

Authors:  Brian D Holt; Joseph H Shawky; Kris Noel Dahl; Lance A Davidson; Mohammad F Islam
Journal:  J Appl Toxicol       Date:  2015-10-28       Impact factor: 3.446

4.  Pachymic acid modified carbon nanoparticles reduced angiogenesis via inhibition of MMP-3.

Authors:  Jun Ma; Jun Liu; Chun-Wei Lu; Ding-Fang Cai
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

5.  Synthesis and characterization of MFe2O4 (M = Co, Ni, Mn) magnetic nanoparticles for modulation of angiogenesis in chick chorioallantoic membrane (CAM).

Authors:  Momin Nooris; Deshmukh Aparna; S Radha
Journal:  Eur Biophys J       Date:  2015-10-22       Impact factor: 1.733

Review 6.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

7.  Chapter 2. Chick embryo chorioallantoic membrane models to quantify angiogenesis induced by inflammatory and tumor cells or purified effector molecules.

Authors:  Elena I Deryugina; James P Quigley
Journal:  Methods Enzymol       Date:  2008       Impact factor: 1.600

8.  Nanotechnology-mediated targeting of tumor angiogenesis.

Authors:  Deboshri Banerjee; Rania Harfouche; Shiladitya Sengupta
Journal:  Vasc Cell       Date:  2011-01-31

Review 9.  Strategies to better treat glioblastoma: antiangiogenic agents and endothelial cell targeting agents.

Authors:  Asbiel Hasbum; Jaqueline Quintanilla; Juan A Amieva Jr; May-Hui Ding; Arkene Levy; Sue Anne Chew
Journal:  Future Med Chem       Date:  2021-01-05       Impact factor: 3.808

10.  Comparison of anti-angiogenic properties of pristine carbon nanoparticles.

Authors:  Mateusz Wierzbicki; Ewa Sawosz; Marta Grodzik; Marta Prasek; Slawomir Jaworski; André Chwalibog
Journal:  Nanoscale Res Lett       Date:  2013-04-26       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.